SEC Form 4 · accession 0001179110-15-000680
KYTHERA BIOPHARMACEUTICALS INC · KYTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Keith R Leonard
Officer — President & CEO · Director
Period of report
Jan 6, 2015
Accepted (ET)
Jan 8, 2015 · 3:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001436304
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 6, 2015 | M | 28,643 | $6.06 | A | 28,643 | D | |
| Common StockF2 | holding | — | — | — | 871,946 | I | See footnote | |
| Common StockF3 | holding | — | — | — | 49,649 | I | See footnote | |
| Common StockF4 | holding | — | — | — | 49,649 | I | See footnote | |
| Common StockF5 | holding | — | — | — | 189 | I | See footnote | |
| Common StockF6 | holding | — | — | — | 189 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.06 | Jan 6, 2015 | M | 28,643 | D | — | Jan 15, 2015 | Common Stock | 28,643 | 0 | D |
Explanation of responses
- F1100% of the shares subject to this option are fully vested and exercisable.
- F2Shares held by Leonard Family Trust, dated August 28, 1996, Keith Richard Leonard, Jr. and Nanette LaRosa Leonard, Trustees.
- F3Shares held by Keith Richard Leonard, Jr., Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee.
- F4Shares held by Nanette LaRosa Leonard, Retained Annuity Trust, Dated 12 April, 2010, Keith Richard Leonard, Jr., Trustee.
- F5Shares held by Keith R. Leonard III. Keith R. Leonard III is the son of the Reporting Person.
- F6Shares held by Nina R. Leonard. Nina R. Leonard is the daughter of the Reporting Person.